Loading
NASDAQHealthcareBiotechnology
Latest quote
$14.5746
+$0.4246 · +3.00%
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.
Regular session
$14.5746
+$0.4246 · +3.00%
Regular session · ET · Market data may be delayed.
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.
Day range
Current $14.5746
52-week range
Current $14.5746
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
37
Expensive
Sentiment
66
Bullish
Risk
57
Elevated Risk
Momentum
67
Gaining
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.
Day range
Current $14.5746
52-week range
Current $14.5746
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of goods sold | — | 282K USD | 96K USD | 68K USD | 15K USD |
| Gross profit | — | −282K USD | −96K USD | −68K USD | −15K USD |
| Research and development | 93.12M USD | 53.19M USD | 64.22M USD | 38.62M USD | 14.99M USD |
| Selling, general, and administrative | 20.42M USD | 21.13M USD | 17.09M USD | 14.55M USD | 8.02M USD |
| Operating expenses | 113.54M USD | 74.31M USD | 81.31M USD | 53.17M USD | 23.01M USD |
| Interest income | 7.78M USD | 5.04M USD | 5.95M USD | 1.83M USD | 65K USD |
| Depreciation and amortization | 26K USD | 282K USD | 96K USD | 68K USD | 15K USD |
| Operating income | −113.54M USD | −74.6M USD | −81.41M USD | −53.24M USD | −23.02M USD |
| Net income | −127.41M USD | −69.63M USD | −75.52M USD | −51.51M USD | −22.96M USD |
Company facts updated Oct 9, 2026.
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$47.83
228.17% upsideLimited analyst sample: 4 ratings. Interpret the distribution with caution.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Apr 29, 2025 | $2.40Irregular | Apr 25, 2025 | — |
Ex-dividend Apr 29, 2025
$2.40
Irregular
Record Apr 25, 2025
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI36.3M0.00%2.3T USD0.03%$381.39+0.48%
State Street SPDR S&P Biotech ETFXBI24.27M0.24%10.11B USD0.35%$152.37+2.06%
iShares Russell 2000 ETFIWM14.86M0.02%77.7B USD0.19%$278.77+0.43%
Vanguard Extended Market ETFVXF10.57M0.01%95.4B USD0.05%$234.68+0.66%
iShares Russell 2000 Growth ETFIWO5.25M0.04%14.04B USD0.24%$356.14+0.76%
Vanguard Russell 2000 ETFVTWO3.99M0.02%18B USD0.06%$112.61+0.45%
Schwab U.S. Small-Cap ETFSCHA3.85M0.02%21.73B USD0.03%$32.795+0.41%
Vanguard Health Care ETFVHT2.78M0.01%22B USD0.09%$317.2+1.07%Vanguard Morningstar Total Stock Market ETFVTIState Street SPDR S&P Biotech ETFXBIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOSchwab U.S. Small-Cap ETFSCHAVanguard Health Care ETFVHTAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
